<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE173nnn/GSE173247/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173247</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>AVIL is a bona fide oncogene in rhabdomyosarcoma</name><description>1. AVIL forms a protein-coding fusion with MARS in rhabdomyosarcoma. 2. AVIL is amplified in some RMSs, and overexpressed in most of the RMSs we tested. 3. Tumor cells are addicted to the MARS-AVIL fusion or overexpression of AVIL. 4. Higher AVIL expression correlates with poor prognosis in sarcoma patients</description><dates><publication>2026/05/28</publication></dates><accession>GSE173247</accession><cross_references><GSM>GSM5264277</GSM><GSM>GSM5264278</GSM><GSM>GSM5264276</GSM><GPL>24676</GPL><SRA>SRP316187</SRA><GSE>173247</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>